RAPT Therapeutics (RAPT) Earnings Date, Estimates & Call Transcripts → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free RAPT Stock Alerts $4.01 -0.03 (-0.74%) (As of 11:37 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 9EstimatedActual EPS (Mar. 7) -$0.80 Beat By $0.05 Consensus EPS (Mar. 7) -$0.85 Get RAPT Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for RAPT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRAPT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RAPT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchWhat President Biden's new law means for investorsWhat's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately. RAPT Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.84)($0.82)($0.83)Q2 20242($0.91)($0.81)($0.86)Q3 20242($0.88)($0.79)($0.84)Q4 20242($0.80)($0.78)($0.79)FY 20248($3.43)($3.20)($3.32)RAPT Earnings Date and InformationRAPT Therapeutics last released its earnings data on March 7th, 2024. The reported ($0.80) EPS for the quarter, topping analysts' consensus estimates of ($0.85) by $0.05. RAPT Therapeutics has generated ($3.07) earnings per share over the last year (($3.07) diluted earnings per share). Earnings for RAPT Therapeutics are expected to grow in the coming year, from ($2.94) to ($2.06) per share. RAPT Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off prior year's report dates.Read More RAPT Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/9/2024Estimated)------- 3/7/2024Q4 2023($0.85)($0.80)+$0.05($0.80)--11/13/2023Q3 2023($0.75)($0.82)($0.07)($0.82)--8/11/2023Q2 2023($0.78)($0.66)+$0.12($0.66)--5/11/2023Q1 2023($0.64)($0.76)($0.12)($0.76)--3/14/2023Q4 2022($0.67)($0.64)+$0.03($0.64)--11/10/2022Q3 2022($0.65)($0.63)+$0.02($0.63)-- Get the Latest News and Ratings for RAPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RAPT Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.75)($0.62)+$0.13($0.62)$0.40 million$0.89 million5/11/2022Q1 2022($0.66)($0.69)($0.03)($0.69)$0.40 million$0.64 million3/10/2022Q4 2021($0.66)($0.61)+$0.05($0.61)$1.50 million$0.76 million11/10/2021Q3 2021($0.62)($0.63)($0.01)($0.63)$1.45 million$0.97 million8/11/2021Q2 2021($0.68)($0.63)+$0.05($0.63)$1.43 million$0.87 million RAPT Therapeutics Earnings - Frequently Asked Questions When is RAPT Therapeutics's earnings date? RAPT Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates. Learn more on RAPT's earnings history. Did RAPT Therapeutics beat their earnings estimates last quarter? In the previous quarter, RAPT Therapeutics (NASDAQ:RAPT) reported ($0.80) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.85) by $0.05. Learn more on analysts' earnings estimate vs. RAPT's actual earnings. How much revenue does RAPT Therapeutics generate each year? RAPT Therapeutics (NASDAQ:RAPT) has a recorded annual revenue of $1.53 million. How much profit does RAPT Therapeutics generate each year? RAPT Therapeutics (NASDAQ:RAPT) has a recorded net income of -$116.80 million. RAPT has generated -$3.07 earnings per share over the last four quarters. What is RAPT Therapeutics's EPS forecast for next year? RAPT Therapeutics's earnings are expected to grow from ($2.94) per share to ($2.06) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Cybin Earnings Results Sagimet Biosciences Earnings Results Regulus Therapeutics Earnings Results Seres Therapeutics Earnings Results Syros Pharmaceuticals Earnings Results Cartesian Therapeutics Earnings Results InterCure Earnings Results Renovaro Earnings Results PDS Biotechnology Earnings Results Skye Bioscience Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:RAPT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts"The Biggest Drug Ever" Is ComingBehind the Markets4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RAPT Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.